Please ensure Javascript is enabled for purposes of website accessibility

2 Cannabis Companies That Are Looking Desperate

By David Jagielski – Jun 26, 2020 at 10:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are these pot stocks in financial trouble?

Investors can't just rely on quarterly earnings results to assess how well a company's doing. Often it's what happens in between those reports that can offer a key glimpse into how well the business performing. And for cannabis companies, a major area of concern these days is cash.

The two companies listed below have recently made moves that could suggest they're desperate to conserve cash. Let's take a look at why that may be the case and whether investors should be concerned.

Acreage Holdings

Acreage Holdings (ACRGF) announced on June 17 that it had obtained short-term funding from an institutional investor for $15 million. The note matures in four months, and it comes at a hefty annual interest rate of 60%.

Stack of cash with marijuana leaves.

Image source: Getty Images.

The high rate of interest may indicate the level of difficulty the company had in obtaining a short-term loan. It could also signify Acreage's desperation -- it has a relatively modest funding need for a short period, so much so that it's willing to pay a large premium in interest. On June 1, Acreage also entered two other funding agreements that would allow it to raise up to $60 million.

In both announcements, on June 1 and June 17, Acreage said the proceeds would be for "working capital and general corporate purposes."

Based on its recent results, it's clear that money may be a growing issue for the company. Acreage released its year-end results on May 29. In them, the company reported cash and cash equivalents of $26.5 million as of Dec. 31, 2019 -- a sharp decline from the $104.9 million it had a year ago. The company burned through $70.9 million in cash from its operating activities over the past year.

These latest moves suggest that things have gotten much worse for Acreage, and that means that shares of the New York-based cannabis producer could fall even lower. The pot stock is down more than 50% in 2020. The Horizons Marijuana Life Sciences ETF (HMLSF -12.28%), by comparison, has declined by just 21%.


Curaleaf Holdings (CURLF 0.30%) is another pot stock that's recently made a surprising move. On June 22, the company announced that it would be revising its deal to acquire Grassroots, a vertically integrated cannabis operator that has facilities and licenses in several states. 

The initial deal was announced on July 17, 2019, and included a transfer of $75 million in cash -- that's no longer required under the revised terms of the deal. The transaction was originally worth $875 million, but with cannabis stocks falling over the past year and the cash component now removed from the purchase price, the deal is worth about $700 million today.

Removing the cash portion of the deal undoubtedly gives Curaleaf a bit more room to breathe. However, when the company released its amended first-quarter results on May 20, there didn't appear to be any signs for concern just yet. With cash and cash equivalents of $176.4 million as of March 31, the company looked to be in good shape. In Q1, Curaleaf used only $1.6 million to fund its day-to-day operations and another $44.8 million on investing activities, which included the purchase of property and equipment.

With the COVID-19 pandemic still in its early stages in March, it's possible that Curaleaf's run into more cash flow issues since the release of its Q1 results. But unlike Acreage, Curaleaf looks to be on much stronger footing given its modest cash burn and strong cash balance.

In Curaleaf's case, the move could be more to do with growth. On June 15, the Massachusetts-based cannabis producer announced that it would be expanding its Select brand into Connecticut. Curaleaf closed the deal to acquire Select on Feb. 1. Select had a strong presence on the west coast, but Curaleaf's been expanding it into more markets, including Michigan and Maryland.

The company initially announced the $948.8 million deal to acquire Select on May 1, 2019.

Shares of Curaleaf are down 11% in 2020.

What does this mean for investors?

The moves these two companies have made in recent weeks underline just how risky the cannabis industry is right now amid the COVID-19 pandemic. Acreage is a stock I'd stay far away from given how aggressive it's been in obtaining funding. It suggests that cash flow is a big problem right now, and that's not something that investors should be taking lightly.

Curaleaf adjusting its deal with Grassroots is also concerning, but the stock doesn't appear to be as risky as Acreage is right now. If nothing else, Curaleaf modifying its deal could be a shrewd way for the company to conserve cash in an acquisition where it doesn't need to spend the money.

Either way, cannabis investors need to be extra careful when buying shares of pot stocks, and cash flow isn't something that they can afford to just gloss over.

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$5.06 (0.30%) $0.01
Acreage Holdings, Inc. Stock Quote
Acreage Holdings, Inc.
Horizons Marijuana Life Sciences Index ETF Stock Quote
Horizons Marijuana Life Sciences Index ETF
$3.94 (-12.28%) $0.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.